Biosimilars-why terminology matters
Nat Biotechnol
.
2011 Aug 5;29(8):690-3.
doi: 10.1038/nbt.1936.
Authors
Martina Weise
,
Marie-Christine Bielsky
,
Karen De Smet
,
Falk Ehmann
,
Niklas Ekman
,
Gopalan Narayanan
,
Hans-Karl Heim
,
Esa Heinonen
,
Kowid Ho
,
Robin Thorpe
,
Camille Vleminckx
,
Meenu Wadhwa
,
Christian K Schneider
PMID:
21822237
DOI:
10.1038/nbt.1936
No abstract available
Publication types
Letter
MeSH terms
Biosimilar Pharmaceuticals / standards*
Clinical Trials as Topic
Drug Approval
Humans
Terminology as Topic*
Therapeutic Equivalency
Substances
Biosimilar Pharmaceuticals